These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33242469)

  • 1. Letter to the editor concerning: Lu Y.P. et al., Non-oxidized PTH (n-oxPTH) is associated with graft loss in kidney transplant recipients, Clin Chim Acta 508 (2020) 92-97.
    Ursem SR; Vervloet MG; Heijboer AC
    Clin Chim Acta; 2021 Jan; 512():18-19. PubMed ID: 33242469
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-oxidized PTH (n-oxPTH) is associated with graft loss in kidney transplant recipients.
    Lu YP; Zeng S; Chu C; Hasan AA; Slowinski T; Yin LH; Krämer BK; Hocher B
    Clin Chim Acta; 2020 Sep; 508():92-97. PubMed ID: 32413401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipients.
    Hocher B; Oberthür D; Slowinski T; Querfeld U; Schaefer F; Doyon A; Tepel M; Roth HJ; Grön HJ; Reichetzeder C; Betzel C; Armbruster FP
    Kidney Blood Press Res; 2013; 37(4-5):240-51. PubMed ID: 23868100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients.
    Zuo J; Hasan AA; Hocher CF; Kalk P; Kleuser B; Krämer BK; Hocher B
    Front Endocrinol (Lausanne); 2023; 14():1178166. PubMed ID: 37324252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between GFR, intact PTH, oxidized PTH, non-oxidized PTH as well as FGF23 in patients with CKD.
    Zeng S; Querfeld U; Feger M; Haffner D; Hasan AA; Chu C; Slowinski T; Bernd Dschietzig T; Schäfer F; Xiong Y; Zhang B; Rausch S; Horvathova K; Lang F; Karl Krämer B; Föller M; Hocher B
    FASEB J; 2020 Nov; 34(11):15269-15281. PubMed ID: 32964520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Only bioactive forms of PTH (n-oxPTH and Met18(ox)-PTH) inhibit synthesis of sclerostin - evidence from in vitro and human studies.
    Li M; Hasan AA; Chu C; Hocher JG; Liu Y; Zhang X; Chen X; Yard B; Krämer BK; Hocher B
    Pflugers Arch; 2024 Jun; 476(6):889-899. PubMed ID: 38393416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation of parathyroid hormone.
    Ursem SR; Vervloet MG; de Jongh RT; Heijboer AC
    Clin Chim Acta; 2020 Jul; 506():84-91. PubMed ID: 32178977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of PTH: in vivo feature or effect of preanalytical conditions?
    Ursem SR; Vervloet MG; Hillebrand JJG; de Jongh RT; Heijboer AC
    Clin Chem Lab Med; 2018 Jan; 56(2):249-255. PubMed ID: 28809747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonoxidized, biologically active parathyroid hormone determines mortality in hemodialysis patients.
    Tepel M; Armbruster FP; Grön HJ; Scholze A; Reichetzeder C; Roth HJ; Hocher B
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4744-51. PubMed ID: 24171919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Activity of Different Forms of Oxidized Parathyroid Hormone.
    Hasan AA; Hocher CF; Kleuser B; Krämer BK; Hocher B
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why Current PTH Assays Mislead Clinical Decision Making in Patients with Secondary Hyperparathyroidism.
    Hocher B; Yin L
    Nephron; 2017; 136(2):137-142. PubMed ID: 28183082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is low pre-transplant parathyroid hormone a risk marker for cardiovascular disease in long-term follow-up of renal transplant recipients?
    Isaksson E; Almquist M; Seeberger A; Sterner G
    Clin Exp Nephrol; 2018 Oct; 22(5):1188-1197. PubMed ID: 29478201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter to the Editor concerning Baecher et al. (Clin Chim Acta 2014;431:87-92).
    Blaustein MP
    Clin Chim Acta; 2015 Aug; 448():248-9. PubMed ID: 26169154
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
    Borrego Utiel FJ; Bravo Soto JA; Merino Pérez MJ; González Carmelo I; López Jiménez V; García Álvarez T; Acosta Martínez Y; Mazuecos Blanca MA
    Nefrologia; 2015; 35(4):363-73. PubMed ID: 26306956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of biological effects of oxidized parathyroid hormone-(1-34) in dogs and rats.
    Galceran T; Lewis-Finch J; Martin KJ; Slatopolsky E
    Endocrinology; 1984 Dec; 115(6):2375-8. PubMed ID: 6499771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cinacalcet pre-transplantation on mineral metabolism in renal transplant recipients.
    Sharma AK; Masterson R; Holt SG; Tan SJ; Hughes PD; Chu M; Jayadeva P; Toussaint ND
    Nephrology (Carlton); 2016 Jan; 21(1):46-54. PubMed ID: 26072678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium and phosphorus metabolism in stable renal transplant recipients.
    Khosroshahi HT; Shoja MM; Azar SA; Tubbs RS; Safa J; Etemadi J; Ardalan MR
    Exp Clin Transplant; 2007 Dec; 5(2):670-2. PubMed ID: 18194119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of serum parathyroid hormone levels in kidney transplant recipients with moderate-to-advanced CKD.
    Kovesdy CP; Molnar MZ; Czira ME; Rudas A; Ujszaszi A; Sarvary E; Ambrus C; Szathmari M; Remport A; Mucsi I
    Nephron Clin Pract; 2011; 118(2):c78-85. PubMed ID: 21150215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients.
    Dumoulin G; Hory B; Nguyen NU; Bresson C; Fournier V; Bouhaddi M; Chalopin JM; Saint-Hillier Y; Regnard J
    Am J Kidney Dis; 1997 May; 29(5):746-53. PubMed ID: 9159310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone: a determinant of posttransplant blood pressure regulation.
    McCarron DA; Muther RS; Plant SB; Krutzik S
    Am J Kidney Dis; 1981 Jul; 1(1):38-44. PubMed ID: 7036714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.